Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers
10.1097/CM9.0000000000003258
- VernacularTitle:Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers
- Author:
Xu’an WANG
1
,
2
,
3
;
Yongrui BAI
;
Ningli CHAI
;
Yexiong LI
;
Enqiang LINGHU
;
Liwei WANG
;
Yingbin LIU
Author Information
1. Department of Biliary and Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine
2. State Key Laboratory of Systems Medicine for Cancers, Shanghai Cancer Institute
3. Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation, Shanghai 200127, China
- Keywords:
Biliary tract carcinoma;
Etiology;
Diagnosis;
Treatment;
Surgery
- From:
Chinese Medical Journal
2024;137(19):2272-2293
- CountryChina
- Language:Chinese
-
Abstract:
Background::Biliary tract carcinoma (BTC) is relatively rare and comprises a spectrum of invasive tumors arising from the biliary tree. The prognosis is extremely poor. The incidence of BTC is relatively high in Asian countries, and a high number of cases are diagnosed annually in China owing to the large population. Therefore, it is necessary to clarify the epidemiology and high-risk factors for BTC in China. The signs associated with BTC are complex, often require collaborative treatment from surgeons, endoscopists, oncologists, and radiation therapists. Thus, it is necessary to develop a comprehensive Chinese guideline for BTC.Methods::This clinical practice guideline (CPG) was developed following the process recommended by the World Health Organization. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess the certainty of evidence and make recommendations. The full CPG report was reviewed by external guideline methodologists and clinicians with no direct involvement in the development of this CPG. Two guideline reporting checklists have been adhered to: Appraisal of Guidelines for Research and Evaluation (AGREE) and Reporting Items for practice Guidelines in Healthcare (RIGHT).Results::The guideline development group, which comprised 85 multidisciplinary clinical experts across China. After a controversies conference, 17 clinical questions concerning the prevention, diagnosis, and treatment of BTC were proposed. Additionally, detailed descriptions of the surgical principles, perioperative management, chemotherapy, immunotherapy, targeted therapy, radiotherapy, and endoscopic management were proposed.Conclusions::The guideline development group created a comprehensive Chinese guideline for the diagnosis and treatment of BTC, covering various aspects of epidemiology, diagnosis, and treatment. The 17 clinical questions have important reference value for the management of BTC.
